A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, and immunogenicity of ABP 980 and pertuzumab combined in a single infusion in healthy subjects
Keyword(s):
2006 ◽
Vol 44
◽
pp. S208-S209
◽
Keyword(s):
2012 ◽
Vol 52
(4)
◽
pp. 1381-1391
◽
1999 ◽
Vol 66
(6)
◽
pp. 625-635
2009 ◽
Vol 53
(9)
◽
pp. 3720-3725
◽
2013 ◽
Vol 13
(4)
◽
pp. 1040-1046
◽
Keyword(s):
2015 ◽
Vol 51
(3)
◽
pp. 525-531
◽
1997 ◽
Vol 41
(6)
◽
pp. 1298-1300
◽
Keyword(s):